An industrial microbiologist by training, Gavin's early career in R&D at Glaxo and SmithKline Beecham is complemented by 12 years experience in the commercialisation of academic research outputs in the UK and in New Zealand.
Gavin was Director of Commercialisation at Massey University, NZ, and more recently co-founder and first MD of the Polybatics group companies (Holdings/Trading), a NZ spinout commercialising a microbial bio-nanotechnology platform.
Gavin returned to the UK in 2007 and worked for the Biosciences KTN and served as a member of the government-sponsored Innovation & Growth Team for Industrial Biotechnology. He joined the BBTC in January 2010.